% alzhub.org library filter
% Source: https://alzhub.org/research?author=Cullen+NC&access=free
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{brum2023-37653254,
  author  = {Brum, W. S. and Cullen, N. C. and Janelidze, S. and Ashton, N. J. and Zimmer, E. R. and Therriault, J. and Benedet, A. L. and Rahmouni, N. and Tissot, C. and Stevenson, J. and Servaes, S. and Triana-Baltzer, G. and others},
  title   = {{A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases}},
  journal = {Nature Aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00471-5},
  pmid    = {37653254},
  url     = {https://doi.org/10.1038/s43587-023-00471-5}
}

@article{mattsson2019-31009028,
  author  = {Mattsson, N. and Cullen, N. C. and Andreasson, U. and Zetterberg, H. and Blennow, K.},
  title   = {{Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.0765},
  pmid    = {31009028},
  url     = {https://doi.org/10.1001/jamaneurol.2019.0765}
}

@article{leuzy2022-34928318,
  author  = {Leuzy, A. and Smith, R. and Cullen, N. C. and Strandberg, O. and Vogel, J. W. and Binette, A. P. and Borroni, E. and Janelidze, S. and others},
  title   = {{Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.4654},
  pmid    = {34928318},
  url     = {https://doi.org/10.1001/jamaneurol.2021.4654}
}

@article{olsson2019-30508027,
  author  = {Olsson, B. and Portelius, E. and Cullen, N. C. and Å, Sandelius and Zetterberg, H. and Andreasson, U. and Höglund, K. and Irwin, D. J. and others},
  title   = {{Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2018.3746},
  pmid    = {30508027},
  url     = {https://doi.org/10.1001/jamaneurol.2018.3746}
}

@article{cullen2021-37117993,
  author  = {Cullen, N. C. and Leuzy, A. and Palmqvist, S. and Janelidze, S. and Stomrud, E. and Pesini, P. and Sarasa, L. and Allué, J. A. and others},
  title   = {{Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations}},
  journal = {Nature aging},
  year    = {2021},
  doi     = {10.1038/s43587-020-00003-5},
  pmid    = {37117993},
  url     = {https://doi.org/10.1038/s43587-020-00003-5}
}

@article{kovacech2024-39580468,
  author  = {Kovacech, B. and Cullen, N. C. and Novak, P. and Hanes, J. and Kontsekova, E. and Katina, S. and Parrak, V. and Fresser, M. and others},
  title   = {{Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01620-7},
  pmid    = {39580468},
  url     = {https://doi.org/10.1186/s13195-024-01620-7}
}

@article{smith2023-36516028,
  author  = {Smith, R. and Cullen, N. C. and Pichet Binette, A. and Leuzy, A. and Blennow, K. and Zetterberg, H. and Klein, G. and Borroni, E. and others},
  title   = {{Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12875},
  pmid    = {36516028},
  url     = {https://doi.org/10.1002/alz.12875}
}